«Targeting the roots of cancer»
Presented by CTI Invest on 07.03.2012
Stemergie develops targeted treatments for cancer-initiating cells (CICs), the roots of cancer.
Based on an innovative technology to identify and target brain cancer-initiating cells, Stemergie identified novel targets for cancer-initiating cells.
New molecules that specifically target brain cancer-initiating cells are now being optimized for development. Stemergie furthermore aims to expand its technology to further cancer indications.
Coach: Dr. Robert Schier / Peter Harboe-Schmidt
| Founded |
2009 |
| Industry |
Biotech & Life Sciences
|
| Status |
looking for investor |